In recent years, opinions on weight loss drugs like Ozempic have shifted dramatically. Perez Hilton, formerly against such medications, now promotes their benefits through his partnership with FuturHealth. He acknowledges the ongoing obesity epidemic in the U.S., where 40% of adults are affected, contributing to serious health concerns. The rise in popularity of GLP-1 agonists has coincided with the first decline in obesity rates in over a decade, with studies showing that these drugs can help individuals lose significant weight. Hilton’s personal journey underscores the complexities of weight loss, including the challenge of food addiction.
I probably would have been very against it back then. But it's not cheating. It's medicine. It's science. It's a real thing - and it works.
If I fall off the wagon, like an alcoholic, it takes so much to get back on.
It's like an alcoholic who can intellectualize in the moment that they shouldn't be drinking but they still do it.
A 2024 KFF survey revealed that about one in eight American adults have tried a GLP-1 agonist.
Collection
[
|
...
]